Targeting SAMHD1 with Hydroxyurea in First-Line Cytarabine-Based Therapy of Newly Diagnosed Acute Myeloid Leukaemia: Results from the HEAT-AML Trial.
Journal of internal medicine(2022)
Key words
acute myeloid leukaemia,cytarabine,hydroxyurea,precision medicine,SAMHD1,targeted therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined